Acellular pertussis vaccines in adults

Infectious Disease Clinics of North America

Volumn 13, Issue 1, 1999, Pages 83-94

  Keitel, W A ^a   Edwards, K M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

ADOLESCENT; ADULT; HUMAN; PERTUSSIS; REVIEW;

EID: 0032911492     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70044-1     Document Type: Article

References (65)

1. T. Aoyama Y. Takeuchi A. Goto Pertussis in adults Am J Dis Child 146 1992 163 166
2. S. Baron E. Njamkepo E. Grimprel Epidemiology of pertussis in French hospitals in 1993 and 1994: Thirty years after a routine use of vaccination Pediatr Infect Dis J 17 1998 412 418
3. M. Cadoz F. Arminjon M.J. Wuentain-Millet Safety and Immunogenicity of Merieux Acellular Pertussis Vaccines in Adult Volunteers Transcript of the Workshop on Acellular Pertussis, September 1986 1986 Department of Health and Human Services Washington, DC
4. L. Cattaneo G.W. Reed D.H. Haase The seroepidemiology of Bordetella pertussis infections: A study of persons ages 1–65 years J Infect Dis 173 1996 1256 1259
5. Centers for Disease Control Pertussis outbreaks—Massachusetts and Maryland MMWR 42 1993 197 200
6. Centers for Disease Control Resurgence of pertussis—United States MMWR 42 1993 952 960
7. J.D. Cherry P.A. Brunell G.S. Golden D.T. Karzon Report of the task force on pertussis and pertussis immunization—1988 Pediatrics 81 1988 933 984
8. C.D. Christie K. Garrison L. Kiely Acellular pertussis vs. meningococcal vaccine trial in hospital workers during the Cincinnati pertussis epidemic [abstract] Clin Infect Dis 25 1997 469
9. D.L. Confer J.W. Eaton Phagocyte impotence caused by an invasive bacterial adenylate cyclase Science 217 1982 948
10. J.L. Cowell E. Hewlett C.R. Manclark Intracellular localization of the dermonecrotic toxin of Bordetella pertussis Infect Immun 25 1979 896 901
11. B.A. Cromer J. Goydos J. Hackell Unrecognized pertussis infection in adolescents Am J Dis Child 147 1993 575 577
12. J.L. Deen C.M. Mink J.D. Cherry Household contact study of Bordetella pertussis infections Clin Infect Dis 24 1995 1211 1219
13. K.M. Edwards M.D. Decker B.S. Graham Adult immunization with acellular pertussis vaccine JAMA 269 1993 53 56
14. K.M. Edwards B.D. Meade M.D. Decker Comparison of 13 acellular pertussis vaccines: Overview and serologic response Pediatrics 96 suppl 1995 548 557
15. J.A. Englund W.P. Glezen L. Barreto Controlled study of a new five-component acellular pertussis vaccine in adults and young children J Infect Dis 166 1992 1436 1441
16. K.M. Farizo S.L. Cochi E.R. Zell Epidemiological features of pertussis in the United States Clin Infect Dis 14 1992 708 719
17. J.E. Gordon R.I. Hood Whooping cough and its epidemiological anomalies Am J Med 222 1951 333 361
18. M. Granstrom G. Granstrom Serological correlates in whooping cough Vaccine 11 1992 445 448
19. M. Granstrom M. Thoren M. Blennow Acellular vaccine in adults: Adverse reactions and immune responses Eur J Clin Microbiol 6 4 1987 18 21
20. S.A. Halperin T.J. Marrie Pertussis encephalopathy in an adult: Case report and review Rev Infect Dis 13 1991 1043 1047
21. Q. He M.K. Viljanen R.M. Olander Antibodies to filamentous hemagglutinin of Bordetella pertussis and protection against whooping cough in school children J Infect Dis 170 1994 705 708
22. B. Hederstedt M. Granstrom Adverse reactions and antibody response to an acellular pertussis toxoid vaccine in adult volunteers Vaccine 7 1989 349 350
23. E. Hewlett Pertussis: Current concepts of pathogenesis and prevention Pediatr Infect Dis 16 1997 S78 S84
24. H. Ibsen The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies Vaccine 14 5 1996 350 368
25. J. Ipsen H.E. Bowen Effects of routine immunization of children with triple vaccine (diphtheria-tetanus-pertussis) Am J Public Health 45 1955 312 318
26. H.S. Izurieta T.A. Kenyon P.M. Strebel Risk factors for pertussis in young infants during an outbreak in Chicago in 1993 Clin Infect Dis 22 1996 503 507
27. P. Jenkins S.W. Clarke Cough syncope: A complication of adult whooping cough Br J Dis Chest 75 1981 311 313
28. D. Jenkinson Duration of effectiveness of pertussis vaccine: Evidence from a 10 year community study BMJ 296 1986 612 614
29. Keitel WA, Edwards K, Englund J, et al: Dose response comparisons of 5 acellular pertussis vaccines in healthy adults [abstract]. Presented at the 34th IDSA Annual Meeting, New Orleans, LA, 1996
30. D.L. Klein Preface-multicenter acellular pertussis vaccine trial: A National Institutes of Health perspective Pediatrics 96 suppl 1995 547
31. H.J. Lambert Epidemiology of small pertussis outbreaks in Kent County Public Health Reports 80 4 1965 365 369
32. J.A. Lichty B. Slavin W.L. Bradford An attempt to increase resistance to pertussis in newborn infants by immunizing their mothers during pregnancy J Clin Invest 17 1938 613 621
33. C.C. Linnemann N. Ramundo P.H. Perlstein Use of pertussis vaccine in an epidemic involving hospital staff Lancet 2 1975 540 543
34. S.S. Long H.W. Lischner A. Deforest Serologic evidence of subclinical pertussis in immunized children Pediatr Infect Dis 9 1990 700 705
35. S.S. Long C.J. Welkon J.L. Clark Widespread silent transmission of pertussis in families: Antibody correlates of infection and symptomatology J Infect Dis 161 1990 480 486
36. A.L. Lopez D.A. Blumberg An overview of the status of acellular pertussis vaccines in practice Drugs 54 2 1997 189 196
37. P. Luttinger The epidemiology of pertussis Am J Dis Child 12 1916 290 315
38. D.W. Maclean Adults with pertussis J R Coll Gen Prac 32 1982 298 300
39. G. Mannerstedt Pertussis in adults J Pediatr 34 1934 596 600
40. Medical Research Council Vaccination against whooping cough: Relation between protection in children and results of laboratory tests BMJ 1 1956 1463 1471
41. J. Mertsola O. Ruuskanen E. Eerola M.K. Viljanen Intrafamilial spread of pertussis J Pediatr 193 3 1983 359 363
42. K.H.G. Mills A. Barnard J. Watkins K. Redhead Cell-mediated immunity to Bordetella pertussis: Role of Th1 cells in bacterial clearance in a murine respiratory infection model Infect Immun 61 1993 399 410
43. C.M. Mink J.D. Cherry P.D. Christenson A search for Bordetella pertussis infection in university students Clin Infect Dis 14 1992 464 471
44. C.M. Mink N.M. Sirota S. Nugent Outbreak of pertussis in a fully immunized adolescent and adult population Arch Pediatr Adolesc Med 148 1994 153 157
45. D.M. Musher W.A. Keitel Severe paroxysmal coughing and pleuritic pain in an adult Hosp Pract (Off Ed) 30 1995 65 67
46. J.D. Nelson The changing epidemiology of pertussis in young infants: The role of adults as reservoirs of infection Am J Dis Child 132 1978 371 373
47. M.E. Nenning H.R. Shinefield K.M. Edwards Prevalence and incidence of adult pertussis in an urban population JAMA 275 1996 1672 1674
48. A.M. Pappenheimer Diphtheria Germanier R. Bacterial Vaccines 1984 Academic Press Orlando 1 36
49. M. Pittman The concept of pertussis as a toxin-mediated disease Pediatr Infect Dis J 3 1984 467 486
50. A. Podda L. Nencioni I. Marsili Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 kDa Vaccine 9 1991 741 745
51. S. Postels-Multani H.J. Schmitt Wirsing von Konig C.H. Symptoms and complications of pertussis in adults Infection 3 1995 139 142
52. P.W. Robertson H. Goldberg B.H. Jarvie Bordetella pertussis infection: A cause of persistent cough in adults Med J Australia 146 1987 522 525
53. D.A. Rutter L.A.E. Ashworth A. Day Trial of a new acellular pertussis vaccine in healthy adult volunteers Vaccine 6 1988 29 32
54. O. Ruuskanen A. Putto-Laurila J. Petre Development of an acellular pertussis vaccine and its administration as a booster in healthy adult 1990 University of Turku, UCL E cole de Sante Publique Turku, Finland. Brussels, Belgium
55. Y. Sato K. Izumiya H. Sato Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis Infect Immun 31 3 1981 1223 1231
56. R. Sekura Y. Zhang R. Roberson Clinical, metabolic, and antibody responses of adult volunteers to an investigational vaccine composed of pertussis toxin inactivated by hydrogen peroxide J Pediatr 143 1988 806 813
57. R.D. Shahin M.J. Brennan Z.M. Li Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis J Exp Med 17 1990 63 73
58. R.W. Steketee S.G.F. Wassilak W.N. Adkins Evidence for high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled J Infect Dis 157 3 1988 434 440
59. B. Trollfors E. Rabo Whooping cough in adults BMJ 283 1981 696 697
60. R. Tuomanen A. Weiss R. Rich Filamentous hemagglutinin and pertussis toxin promote adherence of B. pertussis to cilia Dev Biol Stand 61 1985 197 204
61. V.K. Volk R.Y. Gottshall H.D. Anderson Antibody response to booster dose of diphtheria and tetanus toxoids: Reactions in institutionalized adults and non-institutionalized children and young adults Public Health Rep 78 2 1963 161 164
62. C. Weihl H.D. Riley J.H. Lapin Extracted pertussis antigen Am J Dis Child 166 1963 124 129
63. A. Weiss Mucosal immune defenses and the response of Bordetella pertussis ASM News 63 1997 22 28
64. S.W. Wright K.M. Edwards M.D. Decker M.H. Zeldin Pertussis infection in adults with persistent cough JAMA 273 13 1995 1044 1046
65. J.M. Zhang J.L. Cowell A.C. Steven Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen Dev Biol Stand 61 1985 173 185